Encorafenib trials for Melanoma

6 recruiting trials study Encorafenib in trials listing Melanoma in our tracked data. This is not a statement that it treats the condition.

Recruiting trials

Phase breakdown

Phase 1 2Phase 2 4Not applicable 1

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
NCT04511013 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 331 locations
Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
NCT04045691 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 59 locations
Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases
NCT05026983 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma
NCT06194929 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
Melanoma Metastasized to the Brain and Steroids
NCT03563729 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma
NCT04903119 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations